Pharmaceuticals – BRIC (Brazil, Russia, India, China) Industry Guide

reportlinker.com/p0191858/Pharmaceuticals—BRIC-Brazil-Russia-India-China-Industry-Guide.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Pharmaceutical

* Provides textual analysis of the industry’s prospects, competitive landscape and profiles of the leading companies

* Incorporates in-depth five forces competitive environment analysis and scorecards

* Includes a five-year forecast of the industry

* Inform your business decisions

* Add weight to presentations and marketing materials

* Save time carrying out entry-level research

Table 1: BRIC pharmaceuticals industry, revenue($bn), 2007-16 11

Table 2: BRIC pharmaceuticals industry, revenue($bn), 2007-11 13

Table 3: BRIC pharmaceuticals industry, revenue($bn), 2007-11 14

Table 8: Ach Laboratrios Farmacuticos S.A.: key facts 28

Table 9: Medley Indstria Farmacutica Ltd: key facts 29

Table 10: Sanofi: key facts 30

Table 11: Sanofi: key financials ($) 31

Table 12: Sanofi: key financials (€) 31

Table 13: Sanofi: key financial ratios 31

Table 14: EMS Sigma Pharma: key facts 33

Table 25: Pfizer Inc.: key facts 49

Table 26: Pfizer Inc.: key financials ($) 50

Table 27: Pfizer Inc.: key financial ratios 50

Table 28: AstraZeneca PLC: key facts 52

Table 29: AstraZeneca PLC: key financials ($) 53

Table 30: AstraZeneca PLC: key financial ratios 54

Table 31: Jiangsu Yangtze River Pharmaceutical Group Company Ltd.: key facts 56

Table 42: Dr. Reddy’s Laboratories Limited: key facts 72

Table 43: Dr. Reddy’s Laboratories Limited: key financials ($) 73

Table 44: Dr. Reddy’s Laboratories Limited: key financials (Rs.) 73

Table 45: Dr. Reddy’s Laboratories Limited: key financial ratios 73

Table 46: Cipla Limited: key facts 75

Table 47: Cipla Limited: key financials ($) 76

Table 48: Cipla Limited: key financials (Rs.) 76

Table 49: Cipla Limited: key financial ratios 76

Table 50: Ranbaxy Laboratories Limited: key facts 78

Table 51: Ranbaxy Laboratories Limited: key financials ($) 79

Table 52: Ranbaxy Laboratories Limited: key financials (Rs.) 79

Table 53: Ranbaxy Laboratories Limited: key financial ratios 79

Table 54: Lupin Limited: key facts 81

Table 55: Lupin Limited: key financials ($) 82

Table 56: Lupin Limited: key financials (Rs.) 82

Table 57: Lupin Limited: key financial ratios 83

Table 68: Pharmstandard OJSC: key facts 100

Table 69: Pharmstandard OJSC: key financials ($) 100

Table 70: Pharmstandard OJSC: key financials (RUB) 101

Table 71: Pharmstandard OJSC: key financial ratios 101

Table 72: Sanofi: key facts 103

Table 73: Sanofi: key financials ($) 104

Table 74: Sanofi: key financials (€) 104

Table 75: Sanofi: key financial ratios 104

Table 76: Novartis AG: key facts 106

Table 77: Novartis AG: key financials ($) 107

Table 78: Novartis AG: key financial ratios 107

Table 79: Bayer AG: key facts 109

Table 80: Bayer AG: key financials ($) 110

Table 81: Bayer AG: key financials (€) 110

Table 82: Bayer AG: key financial ratios 111

SOURCE Reportlinker